GlassScriptPhysician profile
Kevin P Mcgarvey
NPI 1770553232
$2,085.87
in general payments reported to CMS, 2019-2025
15 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $1,038 · 2021: $210 · 2022: $209 · 2023: $121 · 2024: $154 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $1,082.50 | 2020-2024 | |
| Stryker Corporation | $258.98 | 2021-2023 | Allopure |
| Mimedx Group, INC. | $164.46 | 2024-2025 | |
| Surgenex LLC | $127.62 | 2025 | Pellograft, Surmatrix, Surgraft |
| Paratek Pharmaceuticals, INC. | $95.67 | 2022-2024 | Nuzyra |
| Organogenesis INC. | $61.78 | 2021-2023 | Puraply |
| Merck Sharp & Dohme LLC | $56.30 | 2019 | |
| Nabriva Therapeutics, Plc | $48.38 | 2021 | |
| Melinta Therapeutics, LLC | $42.10 | 2019 | |
| Depuy Synthes Sales INC. | $38.72 | 2021 | |
| Sanara Medtech INC. | $32.00 | 2024 | Celleraterx |
| Wright Medical Technology, INC. | $25.11 | 2019 | |
| Kci USA, INC. | $22.31 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.00 | 2021 | |
| Orthofix Medical, INC. | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcgarvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.